Daniel J. Wallace, MD

The research of Daniel J Wallace, MD, focuses on systemic lupus erythematosus—genetic susceptibility, environmental risk, biomarkers, clinical trials, patient reported outcome measures, cardiac complications. Dr. Wallace's research interest also includes rheumatoid arthritis—environmental risk, clinical trials, and Sjogren's syndrome—biomarkers, genetics, clinical trials. He has over 430 peer reviewed publications, has written 8 books including the principal lupus textbook, 28 book chapters and has had numerous NIH and Department of Defense grants.

PUBLICATIONS

• Wallace DJ. The use of quinacrine (Atabrine) in rheumatic diseases: a reexamination. Semin. Arthritis Rheum. 1989;18(4):282-296.
• Wallace D, Goldfinger D, Lowe C, Nichols S, Weiner J, Brachman M, Klinenberg JR. A double-blind, controlled study of lymphoplasmapheresis versus sham apheresis in rheumatoid arthritis. N Engl J Med. 1982;306(23):1406-1410.
• Klinenberg JR, Wallace D. Plasmapheresis in Raynaud's disease. Lancet. 1978;1(8077):1310-1311.
• Wallace DJ, Margolin K, Waller P. Fibromyalgia and interleukin-2 therapy for malignancy. Ann Intern Med. 1988;108(6):909.